6 Pharmaceuticals Stocks to Buy Now

Advertisement

The grades of 6 Pharmaceuticals stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an “A” (“strong buy”) or “B” overall (“buy”) rating.

Taro Pharmaceutical Industries Ltd. (TARO) boosts its rating from a C to a B this week. Taro Pharmaceutical Industries Ltd. is engaged in developing, manufacturing, and marketing prescription and over-the-counter pharmaceutical products, as well as active pharmaceutical ingredients in the United States, Canada and Israel. The company also gets A’s in return on equity and free cash flow. For more information, get Portfolio Grader’s complete analysis of TARO stock.

This week, Zoetis, Inc. Class A (ZTS) pushes up from a C to a B rating. The company also gets A’s in earnings surprise and return on equity. For more information, get Portfolio Grader’s complete analysis of ZTS stock.

This is a strong week for Concordia Healthcare Corp. (CXRX). The company’s rating climbs to B from the previous week’s C. The company also gets A’s in sales growth and operating margin growth. For more information, get Portfolio Grader’s complete analysis of CXRX stock.

This week, Pfizer Inc.’s (PFE) ratings are up from a C last week to a B. Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. For more information, get Portfolio Grader’s complete analysis of PFE stock.

Aerie Pharmaceuticals, Inc.’s (AERI) ratings are looking better this week, moving up to a B from last week’s C. For more information, get Portfolio Grader’s complete analysis of AERI stock.

The rating of Parnell Pharmaceuticals Holdings Ltd. (PARN) moves up this week, rising from a C to a B. The company also gets A’s in sales growth. For more information, get Portfolio Grader’s complete analysis of PARN stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/12/6-pharmaceuticals-stocks-to-buy-now-2/.

©2024 InvestorPlace Media, LLC